Search company, investor...

List Pharmaceutical

Founded Year



Acquired | Acquired

About List Pharmaceutical

List Pharmaceutical produces penicillin tablets, capsules, granules, common tablets, capsules, and injections. The company also specializes in chemical synthesis and extraction of raw materials

Headquarters Location

No. 12, Unit 1, Maliuwan Village, Liuli Chang Kechuang Rd Jinjiang Industrial Development District

Chengdu, Sichuan, 610023,


+86 028-8591 8111

Missing: List Pharmaceutical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: List Pharmaceutical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

List Pharmaceutical Frequently Asked Questions (FAQ)

  • When was List Pharmaceutical founded?

    List Pharmaceutical was founded in 2002.

  • Where is List Pharmaceutical's headquarters?

    List Pharmaceutical's headquarters is located at No. 12, Unit 1, Maliuwan Village, Liuli Chang Kechuang Rd, Chengdu.

  • What is List Pharmaceutical's latest funding round?

    List Pharmaceutical's latest funding round is Acquired.

  • Who are the investors of List Pharmaceutical?

    Investors of List Pharmaceutical include Ahon Pharma and List Pharmaceutical.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.